StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > Cash

<< Previous

Bullboard Posts

Next >>

Comment by Liked2Thinkon Jun 21, 2022 8:04pm

167 Views

Post# 34772671

RE:RE:RE:Cash

Likely some accounting trickery so Tripp can somehow make it through another vote

im expecting another fluff piece of nr on Monday maybe two sets of nr fluff.

he thinks if he can wait on another pp at a pathetic amount for tens of millions if not more he will save his job

for him to stay the news has to be real and good. Not more hot air and empty promises. This has to be his last shot. What ceo in recorded history kept their job after a 98 percent drop.

<< Previous

Bullboard Posts

Next >>

How one company is disrupting PoC testing